Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Molecules (Basel, Switzerland)|January 10, 2026
Comparative Analysis of Glycan Composition in Therapeutic Antibodies via Glycan Profiling and Intact Mass AnalysisYoun Seo Chun, Jae Beom Lee, Seongin Seomun, et al.
Molecular Immunology|July 9, 2015
Structural consequences of aglycosylated IgG Fc variants evolved for FcγRI bindingMan-Seok Ju, Jung-Hyun Na, Yeon Gyu Yu, et al.
Computational and Structural Biotechnology Journal|January 11, 2021
Crystal structure of AmpC BER and molecular docking lead to the discovery of broad inhibition activities of halisulfates against β-lactamasesBo-Gyeong Jeong, Jung-Hyun Na, Da-Woon Bae, et al.
Biophysical Journal|October 9, 2014
Beta-amyloid oligomers activate apoptotic BAK pore for cytochrome c releaseJaewook Kim, Yoosoo Yang, Seung Soo Song, et al.
Frontiers in Cellular and Infection Microbiology|January 10, 2019
<i>In vitro</i> and <i>in vivo</i> Inhibitory Activity of NADPH Against the AmpC BER Class C β-LactamaseJung-Hyun Na, Tae Hee Lee, Soo-Bong Park, et al.
Bioengineering (Basel, Switzerland)|November 10, 2022
Functional Expression of the Recombinant Spike Receptor Binding Domain of SARS-CoV-2 Omicron in the Periplasm of <i>Escherichia coli</i>Woo Sung Kim, Ji Hyun Kim, Jisun Lee, et al.
Proteomics|September 25, 2021
Characterization of HLA-A*33:03 epitopes via immunoprecipitation and LC-MS/MSAmir Khan, Ji-Yon Shin, Min Kyung So, et al.
Journal of Biological Engineering|April 18, 2025
Engineering FcRn binding kinetics dramatically extends antibody serum half-life and enhances therapeutic potentialSanghwan Ko, Migyeong Jo, Munsu Kyung, et al.
Molecular Pharmaceutics|July 26, 2024
Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDsJisun Lee, Bomi Kim, Hye-Min Woo, et al.
Pageof 4